Recalls / Active ingredient / Ramipril
Ramipril
3 FDA drug recalls involving the active ingredient “Ramipril”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2024-10-23 | Class II | Ramipril Capsules USP 5 mg, a) 90 count (NDC 68180-590-09), b) 100 count NDC 68180-590-01), and c) 500 count ( | Lupin Pharmaceuticals Inc. |
| 2024-10-23 | Class II | Ramipril Capsules USP 10 mg, a) 90 count (NDC 68180-591-09), b) 100 count NDC 68180-591-01), and c) 500 count | Lupin Pharmaceuticals Inc. |
| 2024-10-23 | Class II | Ramipril Capsules USP 2.5 mg, a) 90 count (NDC 68180-589-09), b) 100 count NDC 68180-589-01), and c) 500 count | Lupin Pharmaceuticals Inc. |